Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Charles Schwab Investment Management Inc.
otakuyassine3@gmail.com Charles Schwab Investment Management Inc. raised its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free...
Biosciences
Steward Partners Investment Advisory LLC Sells 45,168 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Steward Partners Investment Advisory LLC trimmed its holdings in shares of Avidity Biosciences, Inc. (NASDAQ:RNA...
Neurocrine Biosciences (NASDAQ:NBIX) Given New $163.00 Price Target at Guggenheim
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target decreased by stock analysts...
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells $93,007.67 in Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Ingrid Delaet sold 623 shares of...
Canaan Partners XI LLC Has $58.10 Million Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA)
Canaan Partners XI LLC lowered its stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA –...
Arcus Biosciences (NYSE:RCUS) Trading Down 4.5% – What’s Next?
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report)’s stock price dropped 4.5% during trading on...
Sarah Boyce Sells 10,397 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 10,397 shares of...
Castle Biosciences, Inc. (NASDAQ:CSTL) Insider Derek J. Maetzold Sells 2,715 Shares
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 2,715 shares...
Financial Comparison: Allogene Therapeutics (NASDAQ:ALLO) & Precision BioSciences (NASDAQ:DTIL)
Precision BioSciences (NASDAQ:DTIL – Get Free Report) and Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)...
Insider Selling: Arcus Biosciences, Inc. (NYSE:RCUS) CFO Sells 3,594 Shares of Stock
Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) CFO Robert C. Goeltz II sold 3,594...
Investment Analysts’ Recent Ratings Changes for Solid Biosciences (SLDB)
A number of research firms have changed their ratings and price targets for Solid Biosciences...